Navigation Links
Unilens Vision Acquires Aero Contact Lens, Inc.
Date:12/9/2008

LARGO, Fla., Dec. 9 /PRNewswire-FirstCall/ -- Unilens Vision Inc. (OTC Bulletin Board: UVICF; TSX Venture Exchange: UVI), which develops, licenses, manufactures, distributes and markets specialty contact lenses, today announced the acquisition of the specialty gas permeable contact lens manufacturer Aero Contact Lens, Inc. located in Michigan.

Under the terms of the agreement, Unilens acquired certain assets of Aero Contact Lens, Inc. including regulatory approvals, customer lists, trade names and various other resources. The gas permeable Aero Contact Lens Brands acquired through the asset purchase include the V/X Multifocal, the Aspirations Multifocal and the R-2000 Keratoconus Lens. The lenses will be manufactured and marketed by Unilens under their pre-existing product brand names from the Unilens Corp., USA headquarters and manufacturing facility located in Largo, Florida.

Unilens will continue the Aero Contact Lens tradition of excellent customer service and consultation from the Aero Michigan office and current Aero pricing and policy programs will stay in effect to ensure a smooth transition.

"Here at Unilens, known in the industry as 'The Independent Eye Care Professional's Specialty Contact Lens Company,' we have a longstanding commitment to support the growth and strength of high quality independent optometry with some of the best contact lens technology available in the industry today," stated Michael Pecora, Chief Executive Officer of Unilens Vision Inc. "That is why we are so excited to have the Aero Contact Lens Brands as the newest additions to our ever expanding product portfolio that contribute directly to the patient retention and practice profitability of independents across the country. This acquisition, along with the recent launch of the C-Vue(R) Advanced Custom Toric and the C-Vue 1 Day daily disposable, illustrate Unilens' commitment to support independent eye care professionals throughout the U.S.," continued Pecora.

About Unilens Vision Inc. - "The Independent Eye Care Professionals Contact Lens Company"

Established in 1989, Unilens Vision Inc., through its wholly owned subsidiary Unilens Corp., USA, located in Largo, Florida, develops, licenses, manufactures, distributes and markets contact lenses primarily under the C-Vue(R) brand directly to Independent Eye Care Professionals. Additional information on the Company may be accessed on the Internet at www.unilens.com. The Company's common stock is listed on the OTC Bulletin Board under the symbol "UVICF" as well as the Canadian TSX Venture Exchange under the symbol "UVI".

The information contained in this news release, other than historical information, consists of forward-looking statements that involve risks and uncertainties that could cause actual results to differ materially from those described in such statements. For a discussion of certain factors that could cause actual results to differ materially from those described in the forward-looking statements, please refer to the Company's most recent filings with the SEC and the TSX Venture Exchange. The TSX Venture Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.

For more information, please contact:

Kelly McKnight at (727) 544-2531


'/>"/>
SOURCE Unilens Vision Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Unilens Vision Reports Record First Quarter Revenue, Earnings and Royalty Income
2. Unilens Launches New C-VUE(R) Advanced(TM) Custom Toric Lens
3. Unilens Vision Inc. Declares Regular Quarterly Cash Dividend of U.S. $0.09 Per Share
4. Unilens Vision Announces New Policies Aimed at Increasing Eye Care Professionals Profitability
5. Unilens Vision Reports Increased Royalty Income
6. Unilens Launches Aspheric C-VUE(R) Daily Disposable Lens
7. Unilens Vision Inc. Declares Regular Quarterly Cash Dividend of U.S. $0.09 Per Share
8. Unilens Vision Reports 70% Increase in Second Quarter Earnings on Higher Sales and Record Royalty Income
9. Unilens Vision Inc. Declares Regular Quarterly Cash Dividend of U.S. $0.09 Per Share
10. Unilens Vision Reports Record First Quarter Earnings and Royalty Income
11. Unilens Names Eschenbach Optik Exclusive Worldwide Distributor of the UniVision(R) Low Vision Lens
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/18/2017)... (PRWEB) , ... February 18, 2017 , ... ... presets. Use Pixel Film Studios ’ ProParagraph Fashion Volume 2 for ... so many other applications. Users can pick and choose from hand-crafted trend-setting ...
(Date:2/17/2017)... ... 17, 2017 , ... Wells Pharmacy Network offers physicians WellsPx3, ... and non-controlled substances plus the ability to manage orders on their desktop or ... accept electronic prescriptions, according to the Office of the National Coordinator of Health ...
(Date:2/17/2017)... ... 2017 , ... Qualis Health, one of the nation's leading ... DecisionHealth Platinum Awards in recognition of its innovative healthcare management programs that are ... award categories, highlighting four of the organization’s current programs:, , ...
(Date:2/17/2017)... ... 17, 2017 , ... PrideStaff, a national staffing organization, is ... Staffing Industry Analysts' 2017 "Staffing 100 North America" list. , Now in ... to the staffing industry over the last twelve months. Industry insiders and observers ...
(Date:2/17/2017)... ... February 17, 2017 , ... ... planning assistance to families and business owners in the greater Fort Lauderdale metropolitan ... organization. , For more than 30 years, LifeNet 4 Families has provided ...
Breaking Medicine News(10 mins):
(Date:2/16/2017)... Research and Markets has announced the ... Technologies" report to their offering. ... Traditional medical devices include ... non-drug coated implantables, large endoscopes, needle based drug delivery, lab ... last two to three decades for the treatment and management ...
(Date:2/16/2017)... 2017 DaVita Inc. (NYSE: DVA ) ... 31, 2016. Net income attributable to DaVita ... was $158 million, or $0.80 per share and $880 million, ... income attributable to DaVita Inc. for the quarter and year ... was $192 million, or $0.98 per share, and $789 million, ...
(Date:2/16/2017)... , Feb. 16, 2017  Aralez Pharmaceuticals Inc. ... specialty pharmaceutical company, today announced that executive management will ... to be held February 22-23, 2017. Adrian Adams ... the Company at 1:35 p.m. local time on Wednesday, ... audio archive for the event may be accessed from ...
Breaking Medicine Technology: